Skip to main content
Fig. 2 | Journal of Pharmaceutical Health Care and Sciences

Fig. 2

From: Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports

Fig. 2

Plasma viral load and CD4 cell count follow-up from 2009 to 2016 in Case 2. Arrow indicates the time of switching to DTG/RPV dual therapy. X + 0 indicates the time of first administration of anti-retroviral drugs. Abbreviations: TDF/FTC, tenofovir/emtricitabine; ABC/3Tc, abacavir/lamivudine; RPV, rilpivirine; LPV/r, lopinavir/ritonavir; EFV, efavirenz; DTG, dolutegravir

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us